Toshihiko Honkura
Algemeen Directeur bij Quantum Biosystems, Inc.
Actieve functies van Toshihiko Honkura
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Quantum Biosystems, Inc.
 Quantum Biosystems, Inc. BiotechnologyHealth Technology Quantum Biosystems, Inc. is a holding company that develops single-molecule DNA sequencers. It develops and commercializes sequencers based on quantum mechanics. The company was founded by Toshihiko Honkura and Masateru Taniguchi on January 7, 2013 and is headquartered in Osaka, Japan. | Oprichter | 07-01-2013 | - |
| Algemeen Directeur | 07-01-2013 | - | |
| President | 07-01-2013 | - | |
| Directeur/Bestuurslid | 07-01-2013 | - | |
Impute, Inc.
 Impute, Inc. Packaged SoftwareTechnology Services Impute Inc. is a Japanese company that focuses on digital therapeutics with AI-based solutions. The company is based in Tokyo, Japan. The company has developed an autism therapy app that provides a digital-therapeutic program for children with autism spectrum disorder (ASD). Impute Inc. was founded in 2017 by Hirofumi Hamanaka, Kunal A. The CEO is Mayank Singh. | Directeur/Bestuurslid | - | - |
Loopbaan van Toshihiko Honkura
Eerdere bekende functies van Toshihiko Honkura
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| McKinsey & Co. (Japan) | Corporate Officer/Principal | - | - |
Opleiding van Toshihiko Honkura
| University of Tokyo | Graduate Degree |
| The Trustees of Columbia University in The City of New York | Masters Business Admin |
Statistieken
Internationaal
| Japan | 5 |
| Verenigde Staten | 2 |
Operationeel
| Director/Board Member | 2 |
| Chief Executive Officer | 1 |
| Founder | 1 |
Sectoraal
| Consumer Services | 3 |
| Health Technology | 2 |
| Technology Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Quantum Biosystems, Inc.
Quantum Biosystems, Inc. BiotechnologyHealth Technology Quantum Biosystems, Inc. is a holding company that develops single-molecule DNA sequencers. It develops and commercializes sequencers based on quantum mechanics. The company was founded by Toshihiko Honkura and Masateru Taniguchi on January 7, 2013 and is headquartered in Osaka, Japan. | Health Technology |
| McKinsey & Co. (Japan) | |
Impute, Inc.
Impute, Inc. Packaged SoftwareTechnology Services Impute Inc. is a Japanese company that focuses on digital therapeutics with AI-based solutions. The company is based in Tokyo, Japan. The company has developed an autism therapy app that provides a digital-therapeutic program for children with autism spectrum disorder (ASD). Impute Inc. was founded in 2017 by Hirofumi Hamanaka, Kunal A. The CEO is Mayank Singh. | Technology Services |
- Beurs
- Insiders
- Toshihiko Honkura
- Ervaring
